Literature DB >> 3027318

Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.

F C Tortella, L Robles, H I Mosberg.   

Abstract

The opioid receptor types involved in the mediation of enkephalin-induced electroencephalographic (EEG) seizures were studied in unanesthetized, freely moving rats. Four receptor-selective peptide ligands were evaluated for effectiveness in producing nonconvulsive EEG seizures after i.c.v. administration; these included the mu agonist, [D-Ala2-N-methyl-Phe4-Gly5-ol]enkephalin (DAGO), the mixed mu-delta agonist, [D-Ala2-D-Leu5]enkephalin (DADLE), and the selective delta agonists, [D-Pen2-D-Pen5]enkephalin and [D-Pen2-L-Pen5]enkephalin. Only DAGO and DADLE were found to produce EEG seizures, with DAGO being 9 times more potent than DADLE. DAGO produced a greater number of seizure episodes with a greater overall incidence compared with DADLE, reflecting its potent effect to elicit EEG seizure activity in these rats. Injections of [D-Pen2-D-Pen5]enkephalin or [D-Pen2-L-Pen5]enkephalin, even at the highest doses tested, failed to produce seizure activity. Behaviorally, the DAGO and DADLE EEG seizures were nonconvulsive but were temporally associated with episodic bursts of wet-dog shakes. The enkephalin-induced responses were extremely sensitive to antagonism by naloxone and completely blocked by pretreatment with the irreversible mu antagonist beta-funaltrexamine. The selective delta opioid receptor antagonist ICI 174,864 (N,N-diallyl-Tyr-Aib-Aib-Phe-Leu-OH) was ineffective. The use of the most selective agonists and antagonists for mu and delta opioid receptors suggests that, in rats, enkephalin-induced EEG seizures are mediated exclusively by mu opioid receptors and not by delta opioid systems.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027318

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Myoclonus as an acute complication of low-dose hydromorphone in multiple system atrophy.

Authors:  A Hofmann; N Tangri; A-L Lafontaine; R B Postuma
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-08       Impact factor: 10.154

Review 2.  The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.

Authors:  Sunmee Wee; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

3.  Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease.

Authors:  William J Meilandt; Gui-Qiu Yu; Jeannie Chin; Erik D Roberson; Jorge J Palop; Tiffany Wu; Kimberly Scearce-Levie; Lennart Mucke
Journal:  J Neurosci       Date:  2008-05-07       Impact factor: 6.167

4.  Seizure activity involved in the up-regulation of BDNF mRNA expression by activation of central mu opioid receptors.

Authors:  H N Zhang; M C Ko
Journal:  Neuroscience       Date:  2009-03-19       Impact factor: 3.590

5.  17-β-Estradiol induces spreading depression and pain behavior in alert female rats.

Authors:  Alexander J Sandweiss; Karissa E Cottier; Mary I McIntosh; Gregory Dussor; Thomas P Davis; Todd W Vanderah; Tally M Largent-Milnes
Journal:  Oncotarget       Date:  2017-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.